# Safety, tolerability, pharmacokinetics and pharmacodynamics of albiglutide, a long-acting GLP-1-receptor agonist, in Japanese subjects with type 2 diabetes mellitus

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-albiglutide-a-long/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yutaka Seino,Hiromu Nakajima,Hajime Miyahara,Takashi Kurita,Mark Bush,Fred Yang,Murray Stewart,For the Albiglutide Study Group |
| Citations | 45 |
| DOI | 10.1185/03007990903372999 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2167934167 |
| PMID | 19863477 |
| Type | article |
| Year | 2009 |

## Paper authors

- [Fred Yang](https://scholariq.org/researchers/fred-yang/)

## Paper journal

- [Current Medical Research and Opinion](https://scholariq.org/journals/current-medical-research-and-opinion/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.